CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 29,580 shares (gift)
- 4 Exercise or conversion VP, Biology acquired 26,748 shares (option exercise)
- 4 Open-market buy Director bought 15,000 shares at $2.22 ($33,281)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $2.95 ($29,500)
- 4 Open-market buy Director bought 6,335 shares at an average $2.90 ($18,363)
- 4 Open-market buy Head, Translational Research bought 1,000 shares at $3.00 ($2,995)
- 4 Open-market buy SVP, Drug Discovery bought 10,000 shares at $2.48 ($24,824)
- 4 Open-market buy 10% owner bought 60,202 shares at an average $2.61 ($157,267)
- 4 Open-market buy Director bought 50,000 shares at $2.82 ($140,770)
- 4 Open-market buy Director bought 7,500 shares at $2.78 ($20,836)
- 4 Open-market buy CFO & COO bought 15,000 shares at an average $2.88 ($43,225)
Page 12 of 19 · 370 filings